Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-01-20

Clinical Trial Update: HEART to HAART: Smartphone Intervention to Improve HAART Adherence for Drug Users [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a smartphone intervention to improve HAART adherence among people with HIV and drug use disorders has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: HIV, Drug Use Disorders | Phase 2 | Status: COMPLETED